BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,959,000 | +1.5% | 2,850,000 | 0.0% | 0.02% | +5.6% |
| Q1 2019 | $2,916,000 | +2.9% | 2,850,000 | 0.0% | 0.02% | -5.3% |
| Q4 2018 | $2,834,000 | -6.7% | 2,850,000 | 0.0% | 0.02% | +11.8% |
| Q3 2018 | $3,037,000 | +5.5% | 2,850,000 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $2,879,000 | +7.6% | 2,850,000 | 0.0% | 0.02% | +6.2% |
| Q1 2018 | $2,675,000 | -5.8% | 2,850,000 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $2,839,000 | -1.7% | 2,850,000 | 0.0% | 0.02% | -5.9% |
| Q3 2017 | $2,887,000 | – | 2,850,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 23,984,000 | $24,566,321 | 1.87% |
| SSI INVESTMENT MANAGEMENT LLC | 14,019,000 | $14,383,199 | 1.01% |
| PFM Health Sciences, LP | 15,000,000 | $15,427,185 | 0.68% |
| Sonora Investment Management Group, LLC | 6,380,000 | $6,460,377 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,638,000 | $25,339,666 | 0.48% |
| Lombard Odier Asset Management (Europe) Ltd | 9,000,000 | $9,099,180 | 0.45% |
| RWC Asset Management LLP | 11,700,000 | $12,018,591 | 0.37% |
| MACKAY SHIELDS LLC | 10,450,000 | $10,721,491 | 0.29% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,093,000 | $10,326,148 | 0.28% |
| Nicholas Investment Partners, LP | 2,940,000 | $3,016,378 | 0.23% |